1. Home
  2. BOF vs THAR Comparison

BOF vs THAR Comparison

Compare BOF & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOF
  • THAR
  • Stock Information
  • Founded
  • BOF 2017
  • THAR 2017
  • Country
  • BOF United States
  • THAR United States
  • Employees
  • BOF N/A
  • THAR N/A
  • Industry
  • BOF Packaged Foods
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOF Consumer Staples
  • THAR Health Care
  • Exchange
  • BOF Nasdaq
  • THAR Nasdaq
  • Market Cap
  • BOF 27.6M
  • THAR 22.8M
  • IPO Year
  • BOF 2023
  • THAR 2022
  • Fundamental
  • Price
  • BOF $2.96
  • THAR $2.99
  • Analyst Decision
  • BOF
  • THAR Strong Buy
  • Analyst Count
  • BOF 0
  • THAR 1
  • Target Price
  • BOF N/A
  • THAR $17.00
  • AVG Volume (30 Days)
  • BOF 3.7M
  • THAR 271.5K
  • Earning Date
  • BOF 11-13-2025
  • THAR 11-07-2025
  • Dividend Yield
  • BOF N/A
  • THAR N/A
  • EPS Growth
  • BOF N/A
  • THAR N/A
  • EPS
  • BOF N/A
  • THAR N/A
  • Revenue
  • BOF $10,179,595.00
  • THAR N/A
  • Revenue This Year
  • BOF N/A
  • THAR N/A
  • Revenue Next Year
  • BOF N/A
  • THAR N/A
  • P/E Ratio
  • BOF N/A
  • THAR N/A
  • Revenue Growth
  • BOF 95.18
  • THAR N/A
  • 52 Week Low
  • BOF $1.52
  • THAR $0.95
  • 52 Week High
  • BOF $3.21
  • THAR $9.08
  • Technical
  • Relative Strength Index (RSI)
  • BOF 70.89
  • THAR 49.56
  • Support Level
  • BOF $2.00
  • THAR $2.68
  • Resistance Level
  • BOF $3.21
  • THAR $3.21
  • Average True Range (ATR)
  • BOF 0.23
  • THAR 0.28
  • MACD
  • BOF 0.08
  • THAR 0.01
  • Stochastic Oscillator
  • BOF 85.23
  • THAR 38.10

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: